The cell isolation market size has grown rapidly in recent years. It will grow from $4.13 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed in the historical period can be attributed to several key factors. Regulatory support and guidelines have played a crucial role in advancing cell isolation technologies, ensuring their safety and efficacy in various applications. Additionally, the widespread adoption of single-cell analysis techniques has enabled researchers to conduct more precise and detailed studies, unlocking new insights into cellular behavior and function.
The cell isolation market size is expected to see rapid growth in the next few years. It will grow to $7.4 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to rising demand for cell-based assays, adoption of microfluidics-based technologies, increasing funding for life sciences research, expansion of biopharmaceutical industry, expanding research in areas such as cancer and regenerative medicine. Major trends in the forecast period include automation and robotics integration, multiplexed cell isolation, integration of artificial intelligence (AI), single-cell isolation and analysis, miniaturization and portability.
The trajectory of the cell isolation market is set to be influenced by the increasing prevalence of chronic diseases. Chronic illnesses, characterized by their long-term nature, necessitate comprehensive strategies involving public health interventions, lifestyle policies, healthcare infrastructure enhancements, and heightened awareness. This prevalence fuels advancements in cell isolation technologies, unlocking opportunities in stem cell research for regenerative medicine and diverse health treatments. For instance, data from May 2023 released by the Centers for Disease Control and Prevention (CDC.gov) reveals a notable increase in heart disease and cancer deaths in 2022 compared to the previous year, emphasizing the driving force of chronic diseases in shaping the cell isolation market.
Innovative technological strides, such as the closed cell isolation system, are at the forefront of strategies employed by major players in the cell isolation market. These advancements target improved cell purity, workflow efficiency, and therapeutic application efficacy. The closed cell isolation system segregates specific cell populations from heterogeneous samples such as blood or tissue with minimal contamination and optimal cell viability. For example, Sony Corporation's January 2022 launch of the CGX10 closed cell isolation system underscores a paradigm shift beyond research applications into the realm of cell therapy and regenerative medicine. Facilitating the creation of Good Manufacturing Practice (GMP)-compliant manufacturing processes, this innovation amplifies Sony's contribution to advancing cell therapy endeavors.
In January 2021, Gamma Biosciences LP's acquired BioMagnetic Solutions LLC, underscoring strategic moves within the cell isolation market. This acquisition reinforces Gamma Biosciences LP's commitment to investing in innovative entities driving the evolution of cell selection and bioseparation applications. It augments efforts aimed at enhancing the selection and manipulation of specific subsets of therapeutically valuable cells, leveraging next-generation ferrofluid affinity reagents. With BioMagnetic Solutions LLC's expertise in next-generation cell selection and bioseparation technology, Gamma Biosciences LP fortifies its position in pioneering advancements within the sector.
Major companies operating in the cell isolation market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merk Co. & KGaA, GE Healthcare Company, Becton Dickinson & Company, Corning Inc., Lonza Inc., Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Sartorius AG, Terumo Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, STEMCELL Technologies Inc., Cytek Biosciences Inc., Miltenyi Biotec Inc., Neogenomics Laboratories Inc., Promega Corporation, Takara Bio Inc., Molecular Devices LLC, NanoString Technologies Inc., Proteintech Group Inc., Sony Biotechnology Inc., PluriSelect Life Science UG & Co. KG, Invent Biotechnologies Inc., Akadeum Life Sciences Inc.
North America was the largest region in the cell isolation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell isolation is the technique used to extract individual living cells from either a solid tissue block or a suspension of cells. It plays a crucial role in various research fields, including stem cell research, oncology studies, and clinical diagnostics. By targeting specific characteristics such as size, charge, density, shape, or protein expression, cell isolation enables the separation of distinct cell populations from heterogeneous samples. This process is essential for obtaining pure cell populations for further analysis and experimentation.
The primary product categories are consumables and instruments. Consumables play a critical role in enhancing cell growth, productivity, health, and viability, while also reducing the risk of contamination, improving result reproducibility, and minimizing costs. Cell types are broadly categorized into human cells and animal cells, derived from various sources such as bone marrow, adipose tissues, cord blood, and embryonic stem cells. These cells find application across diverse fields including biomolecule isolation, cancer research, stem cell research, tissue regeneration, in-vitro diagnostics, and more. End-users of cell isolation products include pharmaceutical and biotechnology companies, research institutes, academic institutions, hospitals, diagnostic laboratories, and other relevant entities.
The cell isolation market research report is one of a series of new reports that provides cell isolation market statistics, including cell isolation industry global market size, regional shares, competitors with a cell isolation market share, detailed cell isolation market segments, market trends and opportunities, and any further data you may need to thrive in the cell isolation industry. This cell isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell isolation market consists of revenues earned by entities by providing services such as cell sorting services, cell separation services, and cell purification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell isolation market also includes sales of dielectrophoresis (DEP) devices, automated liquid handling systems, microfluidic devices, and immunomagnetic separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cell isolation market size is expected to see rapid growth in the next few years. It will grow to $7.4 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to rising demand for cell-based assays, adoption of microfluidics-based technologies, increasing funding for life sciences research, expansion of biopharmaceutical industry, expanding research in areas such as cancer and regenerative medicine. Major trends in the forecast period include automation and robotics integration, multiplexed cell isolation, integration of artificial intelligence (AI), single-cell isolation and analysis, miniaturization and portability.
The trajectory of the cell isolation market is set to be influenced by the increasing prevalence of chronic diseases. Chronic illnesses, characterized by their long-term nature, necessitate comprehensive strategies involving public health interventions, lifestyle policies, healthcare infrastructure enhancements, and heightened awareness. This prevalence fuels advancements in cell isolation technologies, unlocking opportunities in stem cell research for regenerative medicine and diverse health treatments. For instance, data from May 2023 released by the Centers for Disease Control and Prevention (CDC.gov) reveals a notable increase in heart disease and cancer deaths in 2022 compared to the previous year, emphasizing the driving force of chronic diseases in shaping the cell isolation market.
Innovative technological strides, such as the closed cell isolation system, are at the forefront of strategies employed by major players in the cell isolation market. These advancements target improved cell purity, workflow efficiency, and therapeutic application efficacy. The closed cell isolation system segregates specific cell populations from heterogeneous samples such as blood or tissue with minimal contamination and optimal cell viability. For example, Sony Corporation's January 2022 launch of the CGX10 closed cell isolation system underscores a paradigm shift beyond research applications into the realm of cell therapy and regenerative medicine. Facilitating the creation of Good Manufacturing Practice (GMP)-compliant manufacturing processes, this innovation amplifies Sony's contribution to advancing cell therapy endeavors.
In January 2021, Gamma Biosciences LP's acquired BioMagnetic Solutions LLC, underscoring strategic moves within the cell isolation market. This acquisition reinforces Gamma Biosciences LP's commitment to investing in innovative entities driving the evolution of cell selection and bioseparation applications. It augments efforts aimed at enhancing the selection and manipulation of specific subsets of therapeutically valuable cells, leveraging next-generation ferrofluid affinity reagents. With BioMagnetic Solutions LLC's expertise in next-generation cell selection and bioseparation technology, Gamma Biosciences LP fortifies its position in pioneering advancements within the sector.
Major companies operating in the cell isolation market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merk Co. & KGaA, GE Healthcare Company, Becton Dickinson & Company, Corning Inc., Lonza Inc., Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Sartorius AG, Terumo Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, STEMCELL Technologies Inc., Cytek Biosciences Inc., Miltenyi Biotec Inc., Neogenomics Laboratories Inc., Promega Corporation, Takara Bio Inc., Molecular Devices LLC, NanoString Technologies Inc., Proteintech Group Inc., Sony Biotechnology Inc., PluriSelect Life Science UG & Co. KG, Invent Biotechnologies Inc., Akadeum Life Sciences Inc.
North America was the largest region in the cell isolation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell isolation is the technique used to extract individual living cells from either a solid tissue block or a suspension of cells. It plays a crucial role in various research fields, including stem cell research, oncology studies, and clinical diagnostics. By targeting specific characteristics such as size, charge, density, shape, or protein expression, cell isolation enables the separation of distinct cell populations from heterogeneous samples. This process is essential for obtaining pure cell populations for further analysis and experimentation.
The primary product categories are consumables and instruments. Consumables play a critical role in enhancing cell growth, productivity, health, and viability, while also reducing the risk of contamination, improving result reproducibility, and minimizing costs. Cell types are broadly categorized into human cells and animal cells, derived from various sources such as bone marrow, adipose tissues, cord blood, and embryonic stem cells. These cells find application across diverse fields including biomolecule isolation, cancer research, stem cell research, tissue regeneration, in-vitro diagnostics, and more. End-users of cell isolation products include pharmaceutical and biotechnology companies, research institutes, academic institutions, hospitals, diagnostic laboratories, and other relevant entities.
The cell isolation market research report is one of a series of new reports that provides cell isolation market statistics, including cell isolation industry global market size, regional shares, competitors with a cell isolation market share, detailed cell isolation market segments, market trends and opportunities, and any further data you may need to thrive in the cell isolation industry. This cell isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell isolation market consists of revenues earned by entities by providing services such as cell sorting services, cell separation services, and cell purification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell isolation market also includes sales of dielectrophoresis (DEP) devices, automated liquid handling systems, microfluidic devices, and immunomagnetic separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cell Isolation Market Characteristics3. Cell Isolation Market Trends and Strategies32. Global Cell Isolation Market Competitive Benchmarking33. Global Cell Isolation Market Competitive Dashboard34. Key Mergers and Acquisitions in the Cell Isolation Market
4. Cell Isolation Market - Macro Economic Scenario
5. Global Cell Isolation Market Size and Growth
6. Cell Isolation Market Segmentation
7. Cell Isolation Market Regional and Country Analysis
8. Asia-Pacific Cell Isolation Market
9. China Cell Isolation Market
10. India Cell Isolation Market
11. Japan Cell Isolation Market
12. Australia Cell Isolation Market
13. Indonesia Cell Isolation Market
14. South Korea Cell Isolation Market
15. Western Europe Cell Isolation Market
16. UK Cell Isolation Market
17. Germany Cell Isolation Market
18. France Cell Isolation Market
19. Italy Cell Isolation Market
20. Spain Cell Isolation Market
21. Eastern Europe Cell Isolation Market
22. Russia Cell Isolation Market
23. North America Cell Isolation Market
24. USA Cell Isolation Market
25. Canada Cell Isolation Market
26. South America Cell Isolation Market
27. Brazil Cell Isolation Market
28. Middle East Cell Isolation Market
29. Africa Cell Isolation Market
30. Cell Isolation Market Competitive Landscape and Company Profiles
31. Cell Isolation Market Other Major and Innovative Companies
35. Cell Isolation Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Cell Isolation Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cell isolation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell isolation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell isolation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Consumables; Instruments2) By Cell Type: Human Cells; Animal Cells
3) By Cell Source: Bone Marrow; Adipose Tissues; Cord Blood Or Embryonic Stem Cells; Other Cell Sources.
4) By Application: Biomolecule Isolation; Cancer Research; Stem Cell Research; Tissue Regeneration Or Regenerative Medicines; In-vitro Diagnostics; Other Applications.
5) By End-User: Pharmaceutical And Biotechnology Companies; Research And Academic Institutes; Hospitals And Diagnostic Laboratories; Other End-Users.
Key Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merk Co. & KGaA; GE Healthcare Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merk Co. & KGaA
- GE Healthcare Company
- Becton Dickinson & Company
- Corning Inc.
- Lonza Inc.
- Agilent Technologies Inc.
- Alfa Laval AB
- PerkinElmer Inc.
- Sartorius AG
- Terumo Corporation
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Qiagen NV
- Bio-Techne Corporation
- STEMCELL Technologies Inc.
- Cytek Biosciences Inc.
- Miltenyi Biotec Inc.
- Neogenomics Laboratories Inc.
- Promega Corporation
- Takara Bio Inc.
- Molecular Devices LLC
- NanoString Technologies Inc.
- Proteintech Group Inc.
- Sony Biotechnology Inc.
- PluriSelect Life Science UG & Co. KG
- Invent Biotechnologies Inc.
- Akadeum Life Sciences Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | May 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 4.65 Billion |
| Forecasted Market Value ( USD | $ 7.4 Billion |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
